Wider use of tranexamic acid to reduce surgical bleeding could benefit patients and health systems
- PMID: 38866414
- PMCID: PMC11170764
- DOI: 10.1136/bmj-2024-079444
Wider use of tranexamic acid to reduce surgical bleeding could benefit patients and health systems
Abstract
Ian Roberts and colleagues call for greater use of this inexpensive generic drug that can improve surgical outcomes, avoid unnecessary blood transfusion, and conserve blood stocks
Conflict of interest statement
Competing interests: We have read and understood BMJ policy on declaration of interests and declare that the authors are members of the UK Royal Colleges Tranexamic Acid in Surgery Implementation Group, which includes the Royal College of Surgeons of England, the Royal College of Anaesthetists, the Royal College of Obstetrics and Gynaecology, and the Royal College of Physicians and was established by IR and MRM to promote the use of tranexamic acid in surgery in the UK and internationally. IR has been chief investigator of several large trials of tranexamic acid in acute severe bleeding but has not conducted surgical trials. Provenance and peer review: Not commissioned; externally peer reviewed.
References
-
- National Institute for Health and Care Excellence. Blood Transfusion Quality Standard QS138. 2016. https://www.nice.org.uk/guidance/qs138
-
- NHS Blood and Transplant. National comparative audit of NICE quality standards for transfusion. 2023. https://hospital.blood.co.uk/audits/national-comparative-audit/re...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous